SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-034434
Filing Date
2024-02-13
Accepted
2024-02-13 21:04:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d744273dsc13g.htm SC 13G 49882
  Complete submission text file 0001193125-24-034434.txt   51509
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 24631546
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 8586776077
FORWARD VENTURES V LP (Filed by) CIK: 0001232643 (see all company filings)

IRS No.: 000000000
Type: SC 13G